BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

431 related articles for article (PubMed ID: 26748069)

  • 21. Superior anticancer activity is demonstrated by total extract of Curcuma longa L. as opposed to individual curcuminoids separated by centrifugal partition chromatography.
    Kukula-Koch W; Grabarska A; Łuszczki J; Czernicka L; Nowosadzka E; Gumbarewicz E; Jarząb A; Audo G; Upadhyay S; Głowniak K; Stepulak A
    Phytother Res; 2018 May; 32(5):933-942. PubMed ID: 29368356
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Induction of apoptosis and reduction of MMP gene expression in the U373 cell line by polyphenolics in Aronia melanocarpa and by curcumin.
    Abdullah Thani NA; Sallis B; Nuttall R; Schubert FR; Ahsan M; Davies D; Purewal S; Cooper A; Rooprai HK
    Oncol Rep; 2012 Oct; 28(4):1435-42. PubMed ID: 22842701
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The use of curcumin as an effective adjuvant to cancer therapy: A short review.
    Bashang H; Tamma S
    Biotechnol Appl Biochem; 2020 Mar; 67(2):171-179. PubMed ID: 31608504
    [TBL] [Abstract][Full Text] [Related]  

  • 24. An update on Curcuma as a functional food in the control of cancer and inflammation.
    Schaffer M; Schaffer PM; Bar-Sela G
    Curr Opin Clin Nutr Metab Care; 2015 Nov; 18(6):605-11. PubMed ID: 26418821
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Curcumin nanomedicine: a road to cancer therapeutics.
    Yallapu MM; Jaggi M; Chauhan SC
    Curr Pharm Des; 2013; 19(11):1994-2010. PubMed ID: 23116309
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Turmeric (Curcuma longa) and its major constituent (curcumin) as nontoxic and safe substances: Review.
    Soleimani V; Sahebkar A; Hosseinzadeh H
    Phytother Res; 2018 Jun; 32(6):985-995. PubMed ID: 29480523
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Induction of microRNA-146a is involved in curcumin-mediated enhancement of temozolomide cytotoxicity against human glioblastoma.
    Wu H; Liu Q; Cai T; Chen YD; Wang ZF
    Mol Med Rep; 2015 Oct; 12(4):5461-6. PubMed ID: 26239619
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The beneficial role of curcumin on inflammation, diabetes and neurodegenerative disease: A recent update.
    Ghosh S; Banerjee S; Sil PC
    Food Chem Toxicol; 2015 Sep; 83():111-24. PubMed ID: 26066364
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Combined treatment of AT101 and demethoxycurcumin yields an enhanced anti-proliferative effect in human primary glioblastoma cells.
    Mehner M; Kubelt C; Adamski V; Schmitt C; Synowitz M; Held-Feindt J
    J Cancer Res Clin Oncol; 2020 Jan; 146(1):117-126. PubMed ID: 31844979
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Curcumin-free turmeric exhibits anti-inflammatory and anticancer activities: Identification of novel components of turmeric.
    Aggarwal BB; Yuan W; Li S; Gupta SC
    Mol Nutr Food Res; 2013 Sep; 57(9):1529-42. PubMed ID: 23847105
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Curcumin induces autophagy, inhibits proliferation and invasion by downregulating AKT/mTOR signaling pathway in human melanoma cells.
    Zhao G; Han X; Zheng S; Li Z; Sha Y; Ni J; Sun Z; Qiao S; Song Z
    Oncol Rep; 2016 Feb; 35(2):1065-74. PubMed ID: 26573768
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Terpecurcumins A-I from the rhizomes of Curcuma longa: absolute configuration and cytotoxic activity.
    Lin X; Ji S; Li R; Dong Y; Qiao X; Hu H; Yang W; Guo D; Tu P; Ye M
    J Nat Prod; 2012 Dec; 75(12):2121-31. PubMed ID: 23153397
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Inhibition of GSH synthesis potentiates temozolomide-induced bystander effect in glioblastoma.
    Kohsaka S; Takahashi K; Wang L; Tanino M; Kimura T; Nishihara H; Tanaka S
    Cancer Lett; 2013 Apr; 331(1):68-75. PubMed ID: 23246370
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Preparation and characterization of water-soluble albumin-bound curcumin nanoparticles with improved antitumor activity.
    Kim TH; Jiang HH; Youn YS; Park CW; Tak KK; Lee S; Kim H; Jon S; Chen X; Lee KC
    Int J Pharm; 2011 Jan; 403(1-2):285-91. PubMed ID: 21035530
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Curcumin-enhanced chemosensitivity of FDA-approved platinum (II)-based anti-cancer drugs involves downregulation of nuclear endonuclease G and NF-κB as well as induction of apoptosis and G2/M arrest.
    Wang YT; Liu HS; Su CL
    Int J Food Sci Nutr; 2014 May; 65(3):368-74. PubMed ID: 24438326
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Curcumin suppresses the TPA-induced invasion through inhibition of PKCα-dependent MMP-expression in MCF-7 human breast cancer cells.
    Kim JM; Noh EM; Kwon KB; Kim JS; You YO; Hwang JK; Hwang BM; Kim BS; Lee SH; Lee SJ; Jung SH; Youn HJ; Lee YR
    Phytomedicine; 2012 Sep; 19(12):1085-92. PubMed ID: 22921746
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Curcumin and Its Derivatives as Potential Therapeutic Agents in Prostate, Colon and Breast Cancers.
    Mbese Z; Khwaza V; Aderibigbe BA
    Molecules; 2019 Nov; 24(23):. PubMed ID: 31801262
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Mitochondria as a target in the therapeutic properties of curcumin.
    Trujillo J; Granados-Castro LF; Zazueta C; Andérica-Romero AC; Chirino YI; Pedraza-Chaverrí J
    Arch Pharm (Weinheim); 2014 Dec; 347(12):873-84. PubMed ID: 25243820
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Curcumin as an anti-cancer agent: review of the gap between basic and clinical applications.
    Bar-Sela G; Epelbaum R; Schaffer M
    Curr Med Chem; 2010; 17(3):190-7. PubMed ID: 20214562
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Turmeric: a spice for life?
    Balachandran K; Stebbing J
    Lancet Oncol; 2016 Dec; 17(12):1639. PubMed ID: 27924745
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 22.